Table 1.
References | Subjects | Assessment of auditory function | Assessment of cognition or diagnosis of dementia | Covariates | Principal findings |
---|---|---|---|---|---|
PERIPHERAL AUDITORY DYSFUNCTION | |||||
Anstey et al., 2001 The Australian Longitudinal Study of Aging Australia | 2087 subjects aged 70–96 years | Pure-tone audiometry with portable audiometers | Similarities and DSS from WAIS-R, BNT, and NART | Age | In a 2-year follow-up, decline in hearing was not associated with decline in any cognitive domain |
Anstey et al., 2003 The Australian Longitudinal Study of Aging Australia | 525 subjects, mean age 74.7 years | Pure-tone audiometry with portable audiometers | Similarities and DSS from WAIS-R, BNT, and NART | Age, gender, depressive symptoms, self-rated health, and medical comorbidities | In a 8-year follow-up, a weak association between hearing decline and memory decline was found |
Lin et al., 2004 The Study of Osteoporotic Fractures (SOF) USA | 6112 women aged 69 years and older | Pure-tone audiometry with hand-held audiometers | 3MS and functional status assessed with five activities: walking, climbing stairs, preparing meals, shopping, and doing housework | Medical comorbidities, age, education level, smoking, presence of vertebral fracture, benzodiazepine use, BMI, Lubben social network, grip strength, walking speed, and baseline cognitive or functional status | Combined hearing and vision impairment was associated with cognitive and functional decline after a 4-year follow-up period |
Valentijn et al., 2005 The Maastricht Aging Study The Netherlands | 418 subjects aged 55 years and older | Pure-tone audiometry | VVLT, SCWT, CST, VFT, and LDST | Age, sex, education level, baseline cognitive performance, change in vision or hearing, and baseline vision or hearing | A change in auditory acuity predicted change in memory performance, and auditory acuity at baseline predicted change in the mean score of the first two SCWT cards and the LDST in a 6-year follow-up |
Wallhagen et al., 2008 The Alameda County Study USA | 2002 subjects aged 50–94 years | Self-report | A self-report measure of cognitive functioning | Chronic conditions, age, sex, and education level | In a 5-year follow-up, a relationship between baseline hearing impairment and subsequent poorer cognitive function was found in both existing and new cases of cognitive impairment |
Lin et al., 2011 The Baltimore Longitudinal Study of Aging USA | 639 subjects aged 36–90 years | Pure-tone audiometry | Diagnoses of dementia and AD using DSM-III-R and NINCDS-ADRDA criteria | Sex, age, race, education level, diabetes, smoking, hypertension, and hearing aid use | During a median follow-up of 11.9 years, baseline hearing loss was independently associated with incident all-cause dementia |
Gallacher et al., 2012 The Caerphilly cohort United Kingdom | 1057 men mean age 56.2 years | Pure-tone audiometry. | Diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria. MMSE, CAMCOG, AH4, and CRT | Age, social class, anxiety, and premorbid cognitive ability | Over a 17-year period, auditory threshold was found to be associated with incident dementia and cognitive decline. An additional effect of change in auditory threshold over 8 years was found for nonvascular dementia |
Kiely et al., 2012 The Dynamic Analyses to Optimize Aging Project Australia | 4221 subjects aged 50–103 years | Pure-tone audiometry. | MMSE | Age, sex, diabetes, stroke, hypertension, visual impairment, smoking status, workplace noise exposure, and high-frequency audiometric noise notches | Cognitive impairment and hypertension were independently associated with lower levels and accelerated declines of peripheral hearing, and incidence of cognitive impairment was also associated with poorer hearing function in a 11-year follow-up |
Lin et al., 2013 The Health ABC Study USA | 1984 subjects mean age: 77.4 Years | Pure-tone audiometry. | 3MS and DSS | Age, sex, race/ethnicity, education level, study site, smoking status, hypertension, diabetes mellitus, and stroke history | In a 6-year follow-up, hearing loss was independently associated with accelerated cognitive decline and incident cognitive impairment |
CENTRAL AUDITORY PROCESSING DYSFUNCTION | |||||
Gennis et al., 1991 USA | 112 community-dwelling adults aged 60 years and older | Pure-tone audiometry and SPIN | WMS and JCST | Age and sex | In a 5-years follow-up, no evidence that peripheral or central hearing impairment predicted cognitive decline was found |
Gates et al., 1996 Framingham Heart study USA | Population-based, 1662 people aged 63–95 years | Pure-tone audiometry and SSI-ICM | MMSE and diagnosis of dementia and AD using NINCDS-ADRDA criteria | Age and education level | In a 6-year follow-up, CAP dysfunction in one ear increased the risk of subsequent dementia or cognitive decline; CAP deficit present in both ears doubled the risk |
Gates et al., 2002 Framingham Heart study USA | Population-based, 740 people aged 63–95 years | Pure-tone audiometry and SSI-ICM | MMSE and diagnosis of probable AD using NINCDS-ADRDA criteria | Age, gender, education level, APOE e4 allele presence, and hearing level | In a 8-year follow-up, CAP dysfunction presence was associated with a 10 times higher risk for developing AD |
Gates et al., 2011 The Adult Changes in Thought Study USA | Population-based, 274 people aged 71–96 years | Pure-tone audiometry, SSI-ICM, DSI test, and DDT | CASI and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria | Education level | In a 3-year follow-up, severe CAP dysfunction strongly predicted the risk of a subsequent diagnosis of AD |
Idrizbegovic et al., 2013 Sweden | Case-control, 70 participants aged 50–80 years with MCI or AD and SMC | Pure-tone audiometry, SPIN, and DDT | MMSE, MCI diagnosis, and diagnoses of dementia and AD using DSM-IV and NINCDS-ADRDA criteria | None | In a 1.5-year follow-up, CAP showed a significant decline in the AD group compared with the controls/SMC subjects (left ear) |
DSS, Digit Symbol Substitution subscale; WAIS-R, Wechsler Adult Intelligence Scale-revised; BNT, Boston Naming Test; NART, National Adult Reading Test; 3MS, modified version of Mini-Mental State Examination; BMI, body mass index; VVLT, Visual Verbal Learning Test; SCWT, Stroop Color Word Test; CST, Concept Shifting Task; VFT, Verbal Fluency Test; LDST, Letter-Digit Substitution Test; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, third edition, revised; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association; MMSE, Mini-Mental State Examination; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; CAMCOG, Cambridge Cognitive Examination; AH4, Alice Heim test; CRT, 4-choice reaction time task; SPIN, Speech perception in noise; WMS, Wechsler Memory Scale; JCST, Jacobs Cognitive Screening Test; SSI-ICM, Synthetic sentence identification with either an ipsilateral competing message; APOE, apolipoprotein E; DSI, dichotic sentence identification; DDT, dichotic digits test; CASI, Cognitive Abilities Screening Instrument; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; MCI, mild cognitive impairment; SMC, subjective memory complaints.